Showing results (311-320 of 550) with videos related to
Sort By:
Pageof 55
British Journal of Pharmacology|November 1, 1995
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthasesM R Panara, A Greco, G Santini, et al.Circulation|September 6, 2001
Oxidative stress and platelet activation in homozygous homocystinuriaG Davì, G Di Minno, A Coppola, et al.Circulation|January 20, 1999
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementationG Davì, G Ciabattoni, A Consoli, et al.American Journal of Medical Genetics|May 15, 1993
Inguinal hernia and atrial septal defect in Tel Hashomer camptodactyly syndrome: report of a new case expanding the phenotypic spectrum of the diseaseP Franceschini, M P Vardeu, F Signorile, et al.Haematologica|March 1, 1991
Plasmapheresis in the therapy of hyperthyroidism associated with leukopeniaG De Rosa, A Testa, G Menichella, et al.The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjectsM R Panara, G Renda, M G Sciulli, et al.Circulation|August 19, 1997
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable anginaF Cipollone, P Patrignani, A Greco, et al.Genetics|March 10, 2001
Mapping of avirulence genes in Phytophthora infestans with amplified fragment length polymorphism markers selected by bulked segregant analysisT van der Lee, A Robold, A Testa, et al.Neurology|October 24, 2001
Impaired affective prosody in AD: relationship to aphasic deficits and emotional behaviorsJ A Testa, W W Beatty, A C Gleason, et al.Vaccines|May 28, 2022
Exploring the Association between Misinformation Endorsement, Opinions on the Government Response, Risk Perception, and COVID-19 Vaccine Hesitancy in the US, Canada, and ItalyElena Savoia, Nigel Walsh Harriman, Rachael Piltch-Loeb, et al.Pageof 55